When Sean Duffy, the cofounder and CEO of a digital-health startup called Omada Health, took his first look at the results of his new diabetes-treatment program, he noticed a disturbing trend.
Many of the individuals weren't simply fighting diabetes or obesity. They were also battling psychological issues like depression and anxiety, and those conditions were making their obesity-related symptoms worse.
Duffy wondered if there was more Omada could do to help treat those psychological issues.
So roughly a year ago, he and his team began drafting plans for a program that would focus exclusively on depression and anxiety, while also giving existing customers access to a wider range of mental-health tools. Duffy officially announced the program, which includes a partnership with a mental-health startup called Lantern, on Monday.
Read More: https://www.businessinsider.com/silicon-valley-diabetes-startup-omada-now-tackling-depression-lantern-2019-1
A Silicon Valley startup that pioneered a new way to fight diabetes is tackling depression after its CEO noticed a disturbing trend
Via: Business Insider
Blue Cross Blue Shield of Massachusetts Adds Two New Digital Health Solutions for Large Self-insured Clients
Via: PR Newswire
BOSTON, Jan. 8, 2019 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts (Blue Cross) recently added two new digital health solutions to its Emerging Solutions portfolio—Robin Care for cancer support and Hinge Health for musculoskeletal conditions such as back and knee pain.
Transcarotid artery revascularization with a neuroprotection system was associated with a low rate of stroke in patients with carotid artery stenosis, according to 1-year results of the ROADSTER trial.
Phase 1a Dose-Escalation Data Demonstrates a Favorable Safety Profile and Signals of Immune Cell Modulation in Patients with Late Stage Solid Tumors
OncoMed Announces Interim Phase 1b Results for Navicixizumab and Paclitaxel Combination Therapy in Platinum-resistant Ovarian Cancer
Overall Clinical Benefit Rate of 85%, Partial Response Rate of 42% and Progression Free Survival of 5.4 Months Observed in Patients with > 2 Prior Therapies and/or Prior Bevacizumab
Via: Business Wire
GRAND RAPIDS, Mich.--(BUSINESS WIRE)--Today Priority Health announced it will offer a new digital prevention tool to help members manage their diabetes. Through its partnership with Omada Health, Priority Health will provide clinically-eligible members access to Omada, the country’s leading digital Diabetes Prevention Program (DPP), beginning this month. Priority Health is the first health plan in Michigan to add the Centers for Disease Control and Prevention (CDC) fully recognized digital Diabetes Prevention Program as a preventive benefit.
Objective Responses Observed in Heavily-pretreated Ovarian Cancer Patients Treated with Navicixzumab Monotherapy
Cigna Announces Cigna Ventures with $250 Million to Fund Transformative Innovation and Growth for Health Care
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Today, global health service company Cigna (NYSE: CI) announced the launch of Cigna Ventures, a corporate venture fund focused on transformative and innovative health care companies.
Omada Health made its name with its technology. Now it’s luring insurers with operational innovation
Via: Fierce Healthcare
Inside the San Francisco offices of Omada Health, there’s a tongue-in-cheek term used to describe the company: provendor.
OncoMed Pharmaceuticals, Inc. OMED, +6.44% a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that John Lewicki, Ph.D., President and Chief Executive Officer of OncoMed, will provide a corporate update at two upcoming investor conferences.